asthma
CONCLUSION: In patients with       asthma of moderate or greater severity receiving inhaled corticosteroids,       formoterol taken twice daily resulted in superior bronchoprotection,       bronchodilatation, and clinical control compared with on-demand albuterol over 6        months.
CONCLUSION: In  @OBJECT$   @PREDICAT$         @SUBJECT$  of moderate or greater severity receiving inhaled corticosteroids,       formoterol taken twice daily resulted in superior bronchoprotection,       bronchodilatation, and clinical control compared with on-demand albuterol over 6        months.